Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Uridine Prevents Negative Effects of OXPHOS Xenobiotics on Dopaminergic Neuronal Differentiation.

Iglesias E, Bayona-Bafaluy MP, Pesini A, Garrido-Pérez N, Meade P, Gaudó P, Jiménez-Salvador I, Montoya J, Ruiz-Pesini E.

Cells. 2019 Nov 8;8(11). pii: E1407. doi: 10.3390/cells8111407.

2.

Brain pyrimidine nucleotide synthesis and Alzheimer disease.

Pesini A, Iglesias E, Bayona-Bafaluy MP, Garrido-Pérez N, Meade P, Gaudó P, Jiménez-Salvador I, Andrés-Benito P, Montoya J, Ferrer I, Pesini P, Ruiz-Pesini E.

Aging (Albany NY). 2019 Sep 27;11(19):8433-8462. doi: 10.18632/aging.102328. Epub 2019 Sep 27.

3.

Prenatal exposure to oxidative phosphorylation xenobiotics and late-onset Parkinson disease.

Iglesias E, Pesini A, Garrido-Pérez N, Meade P, Bayona-Bafaluy MP, Montoya J, Ruiz-Pesini E.

Ageing Res Rev. 2018 Aug;45:24-32. doi: 10.1016/j.arr.2018.04.006. Epub 2018 Apr 22. Review.

PMID:
29689408
4.

OXPHOS, pyrimidine nucleotides, and Alzheimer's disease: a pharmacogenomics approach.

Pesini A, Iglesias E, Garrido N, Bayona-Bafaluy MP, Montoya J, Ruiz-Pesini E.

J Alzheimers Dis. 2014;42(1):87-96. doi: 10.3233/JAD-140384.

PMID:
25024340
5.

Stressed cybrids model demyelinated axons in multiple sclerosis.

Llobet L, Gómez-Durán A, Iceta R, Iglesias E, Montoya J, Martín-Martínez J, Ara JR, Ruiz-Pesini E.

Metab Brain Dis. 2013 Dec;28(4):639-45. doi: 10.1007/s11011-013-9410-6. Epub 2013 Apr 24.

PMID:
23612782
6.

Mitochondrial antibiograms in personalized medicine.

Pacheu-Grau D, Gómez-Durán A, Iglesias E, López-Gallardo E, Montoya J, Ruiz-Pesini E.

Hum Mol Genet. 2013 Mar 15;22(6):1132-9. doi: 10.1093/hmg/dds517. Epub 2012 Dec 7.

PMID:
23223015
7.

OXPHOS toxicogenomics and Parkinson's disease.

López-Gallardo E, Iceta R, Iglesias E, Montoya J, Ruiz-Pesini E.

Mutat Res. 2011 Nov-Dec;728(3):98-106. doi: 10.1016/j.mrrev.2011.06.004. Epub 2011 Jul 8. Review.

PMID:
21763451

Supplemental Content

Loading ...
Support Center